Your browser doesn't support javascript.
loading
Final results and overall survival data from a phase II study of acalabrutinib monotherapy in patients with relapsed/refractory mantle cell lymphoma, including those with poor prognostic factors.
Le Gouill, Steven; Dlugosz-Danecka, Monika; Rule, Simon; Zinzani, Pier Luigi; Goy, Andre; Smith, Stephen D; Doorduijn, Jeanette K; Panizo, Carlos; Shah, Bijal D; Davies, Andrew J; Eek, Richard; Jacobsen, Eric; Kater, Arnon P; Robak, Tadeusz; Jain, Preetesh; Calvo, Roser; Tao, Lin; Wang, Michael.
Afiliação
  • Le Gouill S; Institut Curie, Paris.
  • Dlugosz-Danecka M; Maria Sklodowska-Curie National Research Institute of Oncology, Krakow.
  • Rule S; Plymouth University Medical School, Plymouth, UK; AstraZeneca, Mississauga, Ontario.
  • Zinzani PL; IRCCS Azienda Ospedaliero- Universitaria di Bologna Istituto di Ematologia "Seràgnoli"; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna.
  • Goy A; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ.
  • Smith SD; University of Washington, Fred Hutchinson Cancer Center, Seattle, WA.
  • Doorduijn JK; Erasmus MC Cancer Institute, on behalf of the HOVON Lunenburg Lymphoma Phase I/II Consortium, Rotterdam.
  • Panizo C; Hospital Universitario Donostia, San Sebastián.
  • Shah BD; Moffitt Cancer Center, Tampa, FL.
  • Davies AJ; NIHR/Cancer Research UK Experimental Cancer Medicines Centre, University of Southampton Faculty of Medicine, Southampton.
  • Eek R; Border Medical Oncology, Albury, NSW.
  • Jacobsen E; Dana Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Kater AP; Amsterdam University Medical Center, Amsterdam, on behalf of the HOVON Lunenburg Lymphoma Phase I/II Consortium.
  • Robak T; Copernicus Memorial Hospital, Medical University of Lodz, Lodz.
  • Jain P; MD Anderson Cancer Center, University of Texas, Houston, TX.
  • Calvo R; AstraZeneca, Gaithersburg, MD.
  • Tao L; AstraZeneca, South San Francisco, CA.
  • Wang M; MD Anderson Cancer Center, University of Texas, Houston, TX. miwang@mdanderson.org.
Haematologica ; 109(1): 343-350, 2024 Jan 01.
Article em En | MEDLINE | ID: mdl-37470152
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Célula do Manto Tipo de estudo: Prognostic_studies Limite: Adult / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article